Prascend^®

Prascend® tablets are approved by the FDA for the control of Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease) in horses.
The active ingredient pergolide mesylate is a potent dopamine receptor agonist believed to exert its therapeutic effect by stimulating dopamine receptors.

Pituitary Pars Intermedia Dysfunction is one of the most common diseases of the endocrine system that can affect horses. PPID causes the horse's pituitary gland, which utilizes hormones to control body functions, to work overtime.

Supplied as a box of 60 or 160, 1 mg oral tablets.
A veterinarian's prescription is required for purchase.

Ingredients: Each tablet of Prascend® contains 1mg pergolide mesylate.

Rx: Available direct to customers with valid prescriptions: See service area map

Indications: Prascend® is a dopamine receptor agonist for oral use in horses only. Used to control clinical signs of Equine Cushing's Disease (Pituitary Pars Intermediate Dysfunction).

Dosage and Administration: Consult your veterinarian.

Storage: Store At Or Below 25°C (77°F).

Caution: Prascend® tablets should not be crushed due to the potential for increased human exposure. Do not use in horses intended for human consumption.
The use of Prascend® in breeding, pregnant, or lactating horses has not been evaluated. Prascend is a dopamine agonist which may interfere with reproductive hormones and events in breeding, pregnant, or lactating horses.

Shipping: Ships via Ground. Overnight shipping available upon request for a $25 shipping fee on orders up to 5 lbs. Heavier orders require a custom quote. Overnight shipping is not eligible for free shipping.